Release Date Candidiasis Banner Side Graphic
Launch Presentation
 
Needs Assessment
Objectives
Target Audience
Accreditation
CME Credit
Faculty Disclosure Information
Acknowledgement
How to Obtain Credit
Upcoming CME Events
System Requirements
Download Posttest
Sponsor Logos
This CME activity is a web-based audio slide set based on a    September 14, 2005 Satellite Symposium to the 10th Annual Infectious Disease Board Review Course in McLean, Virginia
Presented by:
Thomas F. Patterson, MD, FACP
Director, San Antonio Center for Medical Mycology
Professor of Medicine
Division of Infectious Disease
The University of Texas Health Science Center at San Antonio
San Antonio, Texas

Moderated by:
John E. Bennett, MD, MACP*
Henry Masur, MD*
Bethesda, Maryland


NEEDS ASSESSMENT
The economic and clinical burden of candidiasis is rising due to a variety of disease- and host-related factors, including changing epidemiology of infection and emerging resistance among isolates, as well as changes in patient demographics and delays in diagnosis. Early diagnosis is an essential part of the disease management process to lessen the morbidity and mortality associated with Candida infection. Novel therapies and approaches, including echinocandins, extended-spectrum azoles, and combination regimens, are being evaluated for efficacy and safety.

Return to top of page
OBJECTIVES
Upon completion of this program, clinicians will be able to:
 
  •  
  • Discuss the prevalence of candidiasis among critically ill patients, and its impact on morbidity and mortality
     
  •  
  • Describe tools and techniques that facilitate early diagnosis
     
  •  
  • Assess newer therapeutic approaches for effective treatment, including echinocandins, extended-spectrum azoles, and drug combinations

    Return to top of page
    TARGET AUDIENCE
    This activity has been developed for physicians who care for patients with infectious diseases.

    Return to top of page
    ACCREDITATION
    The Center for Bio-Medical Communication, Inc. (CBC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    This CME activity was planned and produced in accordance with the ACCME Essentials.

    Return to top of page
    CME CREDIT
    CBC designates this educational activity for a maximimum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Return to top of page
    FACULTY DISCLOSURE INFORMATION
    Disclosure is requested when faculty members are confirmed. During their presentation(s), faculty may include discussion of an unlabeled use or an investigative use not yet approved for a commercial product. Therefore, it is incumbent on individuals attending the program to be aware of these factors in interpreting its contents and evaluating its recommendations. Every effort has been made to encourage faculty to disclose any commercial relationships or personal benefits that may be associated with their presentation(s). The following indicates the faculty and nature of those commercial relationships and off-label or investigational product use discussions. Likewise, it is incumbent upon the faculty to disclose such interests/commitments at the beginning of their presentations at the educational activity.

    As part of CBC’s mechanism for resolving potential conflicts of interest, the contents of this activity have undergone peer review by an independent CME reviewer.

    John E. Bennett, MD, MACP* Will not discuss commercial products and/or services
      Will not discuss off-label or investigative product use
      No commercial interest or affiliation
     
    Henry Masur, MD* Will not discuss commercial products and/or services
      Will not discuss off-label or investigative product use
      No commercial interest or affiliation
     
    Thomas F. Patterson, MD, FACP Will discuss commercial products and/or services
      Grant/Research Support – Astellas, Bristol-Myers Squibb, Enzon, Merck, Pfizer, Schering-Plough
      Consultant – Affinium, Astellas, Basilea, Bristol-Myers Squibb, Diversa, Eisai, J. Uriach & Cía. S.A., MediciNova, Merck, Microbia, Nektar Therapeutics, Pfizer, Rib-X, Schering-Plough, Vicuron
      Speakers Bureau – Astellas, Enzon, Merck, Pfizer
      Will discuss off-label or investigative product use

    *Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the activity, although the NIH is not an official sponsor.

    Return to top of page
    ACKNOWLEDGEMENT
    The sponsor of this program gratefully acknowledges the unrestricted educational grant received from Astellas Pharma US, Inc. in support of this activity.

    Return to top of page
    HOW TO OBTAIN CREDIT
    This CME activity is a web-based audio slide set of recorded scientific presentations. Viewers are expected to view the entire presentation before attempting to take the test and completing the activity evaluation.

    Please follow these steps to receive CME credit for viewing and listening to the audio slide set:
     
  •  
  • Review the complete audio slide set activity [ launch presentation ]
     
  •  
  • Click on the link to the CME Posttest/Evaluation to download the PDF
     
  •  
  • Print the Posttest/Evaluation and Answer Sheet
     
  •  
  • Fill out all required personal information on the Posttest/Evaluation answer sheet: Please write legibly as this information will be submitted to the ACCME
     
  •  
  • Answer the Posttest/Evaluation questions on the accompanying answer sheet
     
  •  
  • Mail or fax the answer sheet to CBC using the below information
     
  •  
  • Participants who achieve a score of 70% or better AND respond to the evaluation questions will receive a CME certificate within 6 weeks

    For questions on the CME activity, please contact:
    Jeanne Conway
    Program Coordinator
    Center for Bio-Medical Communication, Inc.
    433 Hackensack Avenue, 9th Floor
    Hackensack, NJ 07601
    Phone: 201-342-5300
    Fax: 201-342-7787
    E-mail: jconway@cbcbiomed.com

    For more information on candidiasis, see: www.doctorfungus.org

    Return to www.cbcbiomed.com for more free CME or to register for a course!

    Return to top of page
    Upcoming CME Events

    Return to top of page